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Peripheral nerve hyperexcitability (PNH) is one of the distal peripheral neuropathy phenotypes often present in patients affected by type
2 diabetes mellitus (T2DM). Through in vivo and ex vivo electrophysiological recordings in db/db mice, a model of T2DM, we observed
that, in addition to reduced nerve conduction velocity, db/db mice also develop PNH. By using pharmacological inhibitors, we demon-
strated that the PNH is mediated by the decreased activity of Kv1-channels. In agreement with these data, we observed that the diabetic
condition led to a reduced presence of the Kv1.2-subunits in juxtaparanodal regions of peripheral nerves in db/db mice and in nerve
biopsies fromT2DMpatients. Together, these observations indicate that theT2DMcondition leads to potassiumchannel-mediatedPNH,
thus identifying them as a potential drug target to treat some of the DPN related symptoms.
Introduction
Diabetic peripheral neuropathy (DPN) is characterized by either
“positive” (paresthesia, dysesthesia, allodynia, cramps, fascicula-
tions) and/or “negative” (hypesthesia, anesthesia, tiredness,mus-
cle weakness) symptoms (Quasthoff, 1998). Previous studies
suggested that changes in neuronal ion channel expression and
function may contribute to DPN symptoms (Quasthoff, 1998;
Misawa et al., 2005, 2009). In myelinated axons, ion channels
are localized at specific spatially restricted domains (Salzer,
2003). Sodium channels (Nav), predominantly containing the
-subunit Nav1.6, are clustered at the node of Ranvier and play a
critical role in the conduction of the action potential. The jux-
taparanodal region is enriched in voltage-gated Shaker-like po-
tassium channels (Kv1) that are responsible for the fast potassium
conductance in axons. In addition, nodal Kv7 channels were re-
cently shown to mediate the slow axonal potassium conductance
(Schwarz et al., 2006). While previous clinical electrophysiologi-
cal studies suggested that peripheral nerve hyperexcitability
(PNH), which is part of the distal peripheral neuropathy pheno-
type present in type 2 diabetesmellitus (T2DM), is a consequence
of alterations in voltage-gated channels (Misawa et al., 2005,
2009), more direct evidence is lacking.
Approximately 90% of all diabetic patients suffer fromT2DM
(Nolan et al., 2011).We therefore decided to getmore insight into
the DPN associated with this form of diabetes by studying a ro-
dent model of T2DM, the db/db mice (Hummel et al., 1966).
Our characterization of db/db animals by electrophysiological
recordings revealed the presence of PNH as part of their DPN
phenotype. We observed that the altered Kv1-channel function
contributes to the PNH phenotype in db/db animals and that
these functional changes are paralleled by altered distribution of
the juxtaparanodal Kv1.2-subunit in peripheral nerves of db/db
mice and in nerve biopsies from T2DM patients indicating the
clinical relevance of our observations.
Materials andMethods
Animals. Db/db breeding pairs were obtained from Janvier, France
[B6.BKS(D)-Leprdb/J; Stock Number: 000697] and the generated ani-
mals were genotyped as previously described (http://jaxmice.jax.org/
strain/000642.html). All animals were housed in a controlled environment
with a 12 h light/12 h dark cycle and free access to water and standard
laboratory diet. Experiments were performed in accordance with the
legal requirements of the University of Lausanne and the Canton of
Vaud.
Only male mice were used in this study. Tail vein blood glucose was
determined with a glucometer Ascencia Contour (Bayer). Plasma in-
sulin levels were measured by using the Rat/Mouse Insulin ELISA Kit
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from Millipore (catalog #EZRMI-13K) according to the manufacturer’s
protocol.
Human biopsies. All donors gave a written consent for the biopsy.
Biopsies of the peroneal nerve and adjacent muscle were performed un-
der local anesthesia, fixed in 3.6% glutaraldehyde and embedded in par-
affin for routine analysis, or were embedded in plastic for semithin and
ultrathin sectioning, analyzed by light and electron microscopy respec-
tively. Paraffin sections were stained with hematoxylin-eosin and Mas-
son’s trichrome. Semithin sections were stained with thionine blue.
Electrophysiology. Nerve conduction velocity recordings and ex vivo
compound action potential (CAP) recordings have been performed as
previously described (Cartoni et al., 2010; de Preux Charles et al., 2010).
For pharmacological analysis, the isolated nerves were exposed to the
drugs between 30 min and 1 h until the effects seemed stable. Tetrodo-
toxin (TTX) was purchased from Enzo Life Sciences, tetraethylammo-
nium (TEA) and 4-aminopyridine (4-AP) from Sigma, and flupirtine
from Tocris Bioscience. All other chemicals were purchased from VWR.
Immunohistochemistry. Mouse tissues were processed as described
previously (Arnaud et al., 2009). Twenty-micrometer-thick sciatic nerve
sections were prepared and fixed with Zamboni’s fixative for 15 min at
room temperature (RT). For immunostainings, the following primary
antibodies were used: Kv1.2 (1:200; NeuroMab, K14/16), pan-Nav (1:
100; Sigma, SP19 S6936), Kv2 (1:100, Alomone, APC-117), Kv1.1
(1:100; Alomone, APC-009) and MBP (1:100, Millipore Bioscience Re-
search Reagents, MAB386) with the appropriate fluorescent secondary
antibodies (Alexa Fluor 594 or 488 conjugated anti-rabbit, anti-mouse or
anti-rat at a dilution of 1:200; Invitrogen). Nile Red staining on teased
fibers was performed as previously described (Arnaud et al., 2009).
Quantitative PCR. RNA extraction, reverse transcription and qPCR con-
ditions have been performed as previously described (Arnaud et al., 2009).
The primers used were as follows: forward 5-CTGGTACCCATCTGCA
AG-3, reverse 5-GTGTGCTCTAGGACTGGATG-3 for Kv1.2; forward
5-AAGGACGGGAAACGCGAGGG-3, reverse5-ATCGATGGACGCTG
GCGGG-3 for Kv1.1; forward 5-AGACAGGCTCCCCCGGGATG-3, re-
verse 5-CATGGCCCGCACGGTCTCTTC-3 for Kv2; forward 5-ACAC
TAGTGGAAGAGCTGGA-3, reverse 5-ACGATCAGGTTCACAATC
TC-3 for Nav1.6; forward 5-TTCACAAGTCTTCTAAGGACTCCTCG-
3, reverse 5-GCACTGGCGTCTGCCG-3 forMPZand forward5-TTGC
TCTTCGTCTCCACCATC-3, reverse 5-TCGTGTGTCCATTGCCCA
C-3 for PMP22. Results were normalized by using the reference gene
-actin (forward primer: 5-GCCCTGAGGCTCTTTTCCAG-3; reverse
primer: 5-TGCCACAGGATTCCATACCC-3).
Western blot analysis. Sciatic nerve endoneurium and dorsal root gan-
glia (DRG) isolated from mice at 23 weeks of age from at least three
animals per genotype were pooled and lysed in ice-cold lysis buffer (20
mM Na2H2PO4, 250 mM NaCl, 1% Triton X-100, SDS 0.1%) supple-
mented with Complete protease inhibitors (Roche). After spin down for
15 min at 4°C, proteins were extracted from the supernatant. Protein
levels were quantified using the Bio-Rad protein assay with BSA as a
standard. Equal amounts of protein extracts were boiled for 5 min at
95°C and were then resolved by 12% SDS-PAGE and electro-transferred
onto a polyvinylidene difluoride membrane (GE Healthcare). Mem-
brane was blocked in Tris-buffered saline containing 0.1% Tween
(TBS-T) supplemented with 5% milk powder for 1 h at RT, and subse-
quently incubated overnight at 4°C in the same buffer supplemented
with antibodies against Kv1.2 (1:500; NeuroMab, K14/16), and standard-
ized using -Actin (1:2000; Sigma, A5316) or /-Tubulin (1:1000, Cell
Signaling Technology, #2148). After washing in TBS-T, blots were ex-
posed to the appropriate horseradish peroxidase-conjugated secondary
antibodies (Dako) in the blocking buffer for 1 h at RT. Finally, the blots
were developed using ECL reagents (Pierce) and Kodak Scientific Imag-
ing Films (Kodak).
Morphometric analysis. Morphometric analysis, including the g-ratio
calculation, was performed as previously described (Arnaud et al., 2009).
Statistics. All data are presented as mean  SEM. P values have been
calculated with the Student’s t test.
Results
Our characterization of db/db mice revealed an increase in body
weight and blood glucose levels at 6 weeks of age. To study the
consequences of T2DM on peripheral nerve function, we ex-
posed the db/db mice to hyperglycemia for 16 weeks (this, based
on the estimated lifespan, represents 10 years in humans).
Therefore, we performed all physiological analysis using 23-
week-old mice. At this age, db/db mice were severely obese and
hyperglycemic. The initial insulin resistance was followed by a
-cell dysfunction leading to a decline in the plasma insulin levels
in db/db mice. Nerve conduction measurements on the sciatic
nerve, containing both motor and sensory fibers, revealed a sig-
nificantly reduced motor nerve conduction velocity (from
40.15 3.49 m/s1 in wild-type (WT) to 30.02 4.46 m/s1 in
db/dbmice, p 0.05) and we also detected a reduction in the tail
sensory nerve conduction velocity (27.32  2.48 m/s1 in WT;
18.62  2.44 m/s1 in db/db mice, p  0.05). Interestingly, the
stimulus threshold to initiate a first response during the motor
nerve conduction studies was significantly lower in db/db mice
compared with WT mice (p  0.0003), indicating hyperexcit-
ability of db/db nerves (Fig. 1a). However, the area and ampli-
tude of the compoundmuscle action potential were not altered in
db/dbmice compared withWTmice at 23 weeks of age (data not
shown).
We extended our above mentioned in vivo electrophysiologi-
cal characterization by ex vivo CAP recordings (Stys et al., 1991)
on sciatic nerves of 23-week-oldmice. The normalized ACAP
amplitude/stimulus strength curves confirmed the presence of an
increased excitability in db/db nerves (Fig. 1b,c). The threshold
(Fig. 1c, see inset) and the stimulus to get 50% of the maximal
CAP amplitude (stim1/2) were significantly reduced (p 0.001).
We observed similar results with thinly myelinated A sensory
fibers (Fig. 1d).
A decrease of fast Kv1-currents in several disease situations
was previously described to induce PNH (Arimura et al., 2002;
Tomlinson et al., 2010; Shibuya et al., 2011). Therefore, we eval-
uated the contribution of Kv1-channels to PNH in T2DM by
exposing isolated sciatic nerves to 4-AP (500 M) and DTX-1
(100 nM), which were previously used to block these channels in
axons (Ro¨per and Schwarz, 1989; Vabnick et al., 1999). As ex-
pected, in WT nerves, Kv1-channel block with 4-AP (Fig. 1b,e)
induced hyperexcitability. The threshold (Fig. 1e, see inset) and
stim1/2 were significantly reduced (p  0.001). Interestingly,
db/db nerve excitability was only barely affected by 4-AP (Fig.
1b,e). Moreover, we observed a similar lack of 4-AP effect on
db/db refractory period (RP; Fig. 1f). DTX-1 changed nerve ex-
citability andRP ofWT and db/db nerves in a similar way but was
less potent than 4-AP (Fig. 1g,h), probably as a consequence of its
previously described more limited diffusion to juxtaparanodal
channels (Devaux andGow, 2008). Together these results suggest
a decreased function of Kv1-channels in db/dbmice that could be
responsible for the observed PNH.
We evaluated the possibility that other ion channels might be
implicated in PNH. Previous studies suggested that PNH in dia-
betic patients could be a consequence of increased persistent
nodal Nav-currents (Misawa et al., 2009). As these currents are
mainly mediated by NaV1.9 TTX-resistant (TTX-R) Nav-
channels (Matsutomi et al., 2006), we tested the sensitivity of
CAPs to TTX. The residual CAP amplitude was similar in WT
and db/db nerves after exposure to 100 nM TTX (respectively
38  2% and 37  6%) and 1 M TTX (2% for both tested
genotypes). AsmutationsaffectingnodalKv7.2 lead toPNH(Taylor
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et al., 1992;Maljevic et al., 2008), we studied a potential role of these
channels in theobservedPNH.WeevaluatedwhetherTEA(10mM),
whichblocks slowpotassiumcurrents in axons (Ro¨per andSchwarz,
1989), would in presence of 4-AP induce a further increase in the
excitability of WT nerves reaching similar values as observed in
db/db nerves. Excitability was not signifi-
cantly affected by coexposure of 4-AP and
TEA either in WT or in db/db nerves (Fig.
1i). Therefore, Kv7- and TTX-R Nav-
channels areunlikelykeyplayers in thePNH
observed in db/dbmice.
We tested whether the PNH could be
reversed by modulation of potentially
preserved ion channels present in db/db
nerves. Flupirtine (10 M), an analgesic
activating Kv7-channels, suppressed PNH
in db/db nerves as revealed by the in-
creased threshold and stim1/2 (p  0.05,
Fig. 1j).
Altered channel localizationmayexplain
the decreased function of Kv1-channels and
the consequent PNH phenotype observed in
23-week-old db/db mice (Devaux, 2010;
Shibuya et al., 2011). Therefore, we charac-
terized the Kv1-channel distribution along
peripheral axons. Teased fibers of sciatic
nerves from 5- and 23-week-old WT mice
coimmunostained for Kv1.2 and pan-Nav
showed typical accumulation of nodal Nav-
subunits and specific localization of jux-
taparanodal Kv1.2-subunits (Fig. 2a). The
same expression pattern was detected in
db/db teased fibers at 5 weeks of age before
the onset of T2DM and DPN (Fig. 2a). In-
terestingly, we observed a strong reduction
of juxtaparanodal Kv1.2-subunits in db/db
teased fibers at 23 weeks of age, whereas
Nav-clusters were well preserved (Fig. 2a).
Quantification revealed that 80%of all ana-
lyzed nodes present a reduced or absent
Kv1.2 signal in db/db mice (Fig. 2a). More-
over, internodal localization of Kv1.2 was
also affected in db/db fibers (Fig. 2b). How-
ever, otherKv1-channel subunits, Kv1.1 and
Kv2,were not affected in db/dbmice com-
pared with WT mice and were normally
distributed even at juxtaparanodes with re-
duced or absent Kv1.2 (Fig. 2c).
Defects in multiple molecular mecha-
nisms can lead to the observed altered
distribution of Kv1.2-channels and we eval-
uated some of them.We tested for potential
changes in expression of ion channel sub-
units in DRG and sciatic nerve endoneu-
rium of 23-week-old mice since it was
previously shown that the alteration in the
distribution of Kv1.2 can be due to their de-
creased expression in the neurons (Shibuya
et al., 2011). InDRG,weobservednodiffer-
ences in the mRNA expression levels of
Kv1.2, Kv2 and Nav1.6 (the major subunit
of nodal Nav-channels) while Kv1.1 showed
a slight upregulation (Fig. 2d). Moreover,
the protein expression of the mature (glycosylated) and immature
isoforms of Kv1.2 in DRG and in sciatic nerve endoneurium
was similar between db/db and WT mice (Fig. 2e) indicating that
Kv1.2 is normally expressed and transported to the axon.
Demyelination is also known to affect juxtaparanodal Kv1-channel
Figure1. Hyperexcitability of db/dbperipheral nerves ismediatedbydecreasedKv1-channel function.a, In vivomeasurements
of the threshold stimulus to induce a first compound muscle action potential on sciatic nerves. The threshold is significantly
decreased in db/db (n 20) comparedwithWT (n 20)mice.b–j, Data obtained by performing ex vivo recordings of compound
action potentials (CAPs) on isolatedmouse sciatic nerves. All exceptd are related to A CAPs.b, Typical traces of CAPs ofWT and
db/dbnerves at different stimulus strengths (300mVor the one to get themaximal amplitude) in presence or absence of 4-AP. The
amplitudes of the traces are normalized to get the samemaximum amplitude in WT and db/db nerves. c, A CAP amplitude of
WT (n11) anddb/db (n12) nerves normalizedby themaximal amplitude as a functionof the stimulus strength.Weobserved
a leftward shift of the db/db curve corresponding to peripheral nerve hyperexcitability (PNH). Inset: a significantly reduced
threshold in db/db nerves confirms PNH. d, A CAP amplitude/stimulus strength curves. As for larger A fibers, thinly myelin-
ated A sensory fibers aremore excitable in db/db (n 5) comparedwithWT (n 7) nerves. Inset: the threshold to generate an
A CAP is also significantly decreased in db/dbnerves.e, 4-AP (500M), a blocker of Kv1-channels, induces hyperexcitability inWT
(n 6) but not in db/db (n 6) nerves, suggesting decreased function of these juxtaparanodal potassium channels. f, Effect of
4-AP on A CAP refractory period (RP). The RP is represented as the ratio of the second CAP on the first CAP amplitude (second
CAP/first CAP) as a function of the interpulse interval (t). 4-AP increases RP significantlymore inWT (n 6) than in db/db (n
6) nerves confirming a decrease in Kv1-channel function. g, DTX-1, a toxin specifically blocking Kv1-channels, has a similar effect
than 4-AP on db/db andWT nerve excitability (n 6). h, Effect of DTX-1 on RP. As for 4-AP, WT RP (n 6) is more increased by
DTX-1 than db/db RP (n 6). i, Effect of coexposure of TEA (10 mM) with 4-AP (500M) on nerve excitability. TEA, which blocks
nodal Kv7-channels, does not induce any further increase in excitability in WT (n 5) or in db/db (n 4) nerves. Therefore, a
change in Kv7-channels is unlikely to be responsible for PNH in db/db nerves. j, Flupirtine (10M), an activator of Kv7-channels,
significantly decreases db/db nerve excitability (n 5) thus reversing PNH as shownby the curves. Inset: threshold increases back
toWT values. Error bars indicate SEM. *p 0.05; **p 0.01; ***p 0.001. Legends for c–d, e–f, and g–h are shown between
them.
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clustering (Arroyoet al., 2004).Weanalyzed themyelinmorphology
of db/db mice at 23 weeks of age. Semithin cross sections (Fig. 2f)
and g-ratio [ratio between axonal area and total (axonalmyelin)
area] measurements (Fig. 2g) as well as qPCR analysis (Fig. 2d) for
two important peripheral myelin genes (MPZ and Pmp22) failed to
reveal any demyelination in db/db mice. Moreover, no segmental
demyelinationwasobservedbyNileRed stainings on teased fibers of
db/db mice compared with WT mice (Fig. 2f). Together these ob-
servations indicate that, most probably, the Kv1.2-channel anchor-
ing into the axolemmamay be affected under diabetic condition.
To assess the clinical relevance of our data, we evaluated the
channel distribution in nerve biopsies from T2DM patients with
a predominantly axonal form of DPN (Table 1 and Fig. 3a). Co-
immunostainings of Kv1.2 and pan-Nav on longitudinal sections
of the peroneal nerve, a major branch of the mixed sciatic nerve,
of control subjects revealed the typical accumulation of nodal
Nav-channels and juxtaparanodal Kv1-channels. Similar to the
phenotype of db/db mice, we observed a significant reduction of
juxtaparanodal Kv1.2-subunits in all analyzed T2DM patients
(Fig. 3a) while nodal Nav-clusters were well preserved. Eighty-
seven percent of the counted nodes had an impaired or absent
Kv1.2 signal in T2DM patients (Fig. 3a). Although all T2DM
patients presented a loss of myelinated fibers (Table 1), none of
them showed obvious signs of segmental demyelination (Fig. 3b).
Figure 2. Kv1.2 distribution is altered in db/dbmice. a, At 5 weeks of age, before the onset of T2DM and DPN in db/dbmice, nodal Nav-channels and juxtaparanodal Kv1.2-subunits are correctly
clustered in teased fibers from bothWT (n 2) and db/dbmice (n 3). At 23weeks of age,WTmice (n 6) show the typical expression pattern of Kv1.2 and Nav but in db/db teased fibers (n
6) the Kv1.2 expressionwas significantly reduced. However, the nodal Nav-clusters remained unaffected. Bar graphs on the right illustrate the percentage of juxtaparanodeswith reduced or absent
Kv1.2 signal of 100 counted nodes. Arrowheads present in a, c, f mark the localization of nodal regions. b, Internodal Kv1.2 localization is altered in 23-week-old db/db mice compared with
age-matchedWTmice. Schmidt-Lanterman incisures apposing localization is indicated by arrows. c, At 23 weeks of age, all juxtaparanodal regions show colocalization of Kv1.2 and Kv1.1 or Kv2
respectively inWTmice (n 3).While also in db/dbmice (n 3) Kv1.1 or Kv2 are appropriately positioned in all juxtaparanodal regions, Kv1.2 is lost in some of the regions (red staining).d, qPCR
data showing that, except for amild increase of Kv1.1, all ion channel subunits are normally expressed in db/db comparedwithWTDRGs (n 3). The peripheralmyelin genesMPZ and Pmp22 show
no difference in their expression level in db/db andWT sciatic nerve endoneurium. e, Kv1.2 protein expression of bothmature and immature isoforms is not reduced in db/db DRGs and sciatic nerve
endoneurium compared with WT levels (n 3). f, Toluidine blue-stained semithin cross sections and Nile red-stained teased fibers of WT (n 3) and db/db (n 3) sciatic nerves show that 16
weeks of hyperglycemia has no detectable effect on the axonal andmyelin structures. g, The g-ratio corroborates this result (n 3). Scale bars in a, c, f: 20m; in b: 8m. Error bars indicate SD;
*p 0.05.
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Discussion
Similar to previously published data (Hummel et al., 1966; Her-
berg andColeman, 1977; Robertson and Sima, 1980)we observed
a relatively early onset of T2DM in db/db mice. This diabetic
phenotype was progressive and accompanied by DPN. Impor-
tantly, we have identified, for the first time, the presence of PNH
in db/db mice thus validating it as a model to characterize this
part of the DPN phenotype. Similar to the situation in diabetic
patients where PNH is thought to be responsible of the positive
symptoms (Quasthoff, 1998; Misawa et al., 2005, 2009), it could
explain allodynia in db/db mice (Cheng et al., 2009).
Using ex vivo CAP recordings, we have clearly demonstrated
that a reduced activity of Kv1-channels was involved in the PNH
phenotype of db/db mice. A role of other channels (e.g., Kv7.2 or
NaV-channels) is unlikely critical but cannot be completely ruled
out. Kv1-channels are clustered at the juxtaparanodal regions and
along the internodes of myelinated peripheral axons (Salzer,
2003). It was previously observed that paranodal/juxtaparanodal
potassium binding sites are reduced in nerves from diabetic pa-
tients (Seneviratne andWeerasuriya, 1974). We have specifically
shown that the Kv1.2 distribution is altered in both db/db mice
and in T2DM nerve biopsies thus providing, to our knowledge,
the first direct demonstration of such an alteration in axonal ion
channels in diabetic patients. Importantly, previous clinical stud-
ies already demonstrated that alterations inKv1-channel function
may lead to PNH or myokymia in different pathological situa-
tions (Arimura et al., 2002; Tomlinson et al., 2010; Shibuya et al.,
2011).
We excluded a reduction of Kv1.2 expression in the soma of
neurons as the cause of the decreased Kv1.2 signal in axons. Fur-
thermore, we did not observe any accumulation ofKv1.2 subunits
in DRG of db/dbmice and its expression (as detected byWestern
blot) was normal in sciatic nerve endoneurium suggesting that
axonal targeting ofKv1.2 is not responsible for the phenotype.We
also clearly excluded a demyelinating phenotype in db/db and
human nerves as being the cause of the altered Kv1.2 distribution.
Interestingly, it was previously observed that the absence of
Caspr2 or TAG-1, two adhesion molecules responsible for the
juxtaparanodal targeting of Kv1.2, lead to redistribution of Kv1.2-
channels to the internodal regions (Poliak et al., 2003). However,
in db/db mice even the internodal Kv1.2 localization is affected
suggesting that the diabetic condition leads to a diffuse Kv1.2
distribution along the axolemma. As opposed to most ion chan-
nel subunits which possess intrinsic targeting motifs, both the
membrane targeting and TAG1-mediated clustering of Kv1.2 is
mainly dependent on its phosphorylation status (Gu and Gu,
2011) which might be affected under diabetic condition. Further
experiments are therefore needed to clarify the mechanisms un-
derlying the observed Kv1.2 mislocalization.
Our data indicate at least two different approaches how to
improve DPN condition (particularly PNH) for which there are
no effective therapies. First, one may try to enhance the targeting
of Kv1.2 to its juxtaparanodal and internodal locations thus im-
proving the hypersensitivity phenotype. Alternatively, our ex-
pression and pharmacology data generated in db/db mice
Table 1. Clinical profile of diabetic and control subjects
Patient Sex Age (y) Age of onset of T2DM (y) Neuropathy Symptoms Nerve biopsy
08N01013 M 52 Unaffected by T2DM — Neurogenic muscular atrophy, sensory defects until
knee, squeezed lateral cutaneous nerve from
thigh to spinal cord
Normal
09N01460 F 63 Unaffected by T2DM — Chronic neurogenic muscular atrophy, walking/
balance problems since 2 years, progressive,
sensory defects
Normal
10N00090 M 51 Unaffected by T2DM Impairment of L5-S1 (bilateral) Muscular atrophy, disease of vertebral discs, pain,
motor and sensory defects
Normal, rare regeneration
08N00894 M 57 54 Axonal Fast progressive motor defects, sensory defects in
lower limbs, amyotrophy
Loss of medium/small size myelinated fibers as
well as unmyelinated fibers, WD, infiltration of
immune cells
09N01529 F 72 58 Axonal Progressive motor/sensory defects since 4 years,
hypoesthesia, reduced balance/vibration sense
Loss of medium/small size myelinated fibers as
well as unmyelinated fibers, signs of WD and
microangiopathy
10N00300 M 41 n.d. Axonal and demyelinating Paresthesia of lower limbs since 6 months, sensory
defects of all four limbs
Moderate loss of large myelinated fibers, WD and
edema, inflammatory processes, diabetic mi-
croangiopathy
WD, Wallerian degeneration; n.d., not determined;—, not detected.
Figure3. AlteredKv1.2 distribution in peripheral nerves of diabetic patients.a, Longitudinal
sections of peroneal nerve biopsies from T2DM (n 3) and control subjects (n 3) were
immunostained for Nav and Kv1.2. In control subjects, Nav-channels accumulate at the node of
Ranvier and Kv1.2-channels at the juxtaparanode. Interestingly, as observed in db/db mice,
T2DMpatients showa striking loss of juxtaparanodal Kv1.2-channels. Thebar graphon the right
represents the percentage of juxtaparanodal regions with reduced or abnormal Kv1.2 distribu-
tion (100 nodes per controls and subjects were counted). b, Immunostaining for MBP and Nav
onhumanbiopsies didnot reveal anypresenceof segmental demyelination indiabetic subjects.
Arrowheads mark the localization of nodal regions. Scale bars: 10m. Error bars indicate SD;
*p 0.05.
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showed that there are multiple ion channel-types (including
Nav1.6, Kv1.1, Kv7.2 and Kv7.3) that are well preserved in the
diabetic peripheral nerve. Both the inhibition of Nav-channels
and the activation of preserved Kv-channels might alleviate the
PNHphenotype.We validated the clinical potential of the second
approach by suppressing PNH in db/db nerves with the Kv7-
activator flupirtine. Interestingly, flupirtine, which is an analge-
sic, has been shown previously to suppress PNH resulting from
exposure of rat and human peripheral nerves to oxaliplatin (Sittl
et al., 2010).
In conclusion, we demonstrated that Kv1-channels, particu-
larly Kv1.2, play a critical role in the PNH phenotype of db/db
mice and corroborated these data with the characterization of
biopsies from T2DM patients. We anticipate that these results
may have direct clinical implications for the development of new
treatments against T2DM-related PNH.
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